A Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against COVID-19.

Name: A Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against COVID-19.
License: Public Domain

Hipra Scientific, S.L.U

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

covid-19, sars-cov-2 acute respiratory disease

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 158054
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.